Literature DB >> 3573054

Obstructive jaundice and cholangitis.

T C Simmons.   

Abstract

Entities:  

Mesh:

Year:  1987        PMID: 3573054      PMCID: PMC2571518     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


× No keyword cloud information.
  10 in total

1.  Gallstone migration as a cause of acute pancreatitis.

Authors:  J M Acosta; C L Ledesma
Journal:  N Engl J Med       Date:  1974-02-28       Impact factor: 91.245

2.  Gallsonte pancreatitis.

Authors:  T R Kelly
Journal:  Arch Surg       Date:  1974-08

3.  Endoscopic sphincterotomy in clinical practice.

Authors:  T C Simmons; D R Henderson; F Gletten
Journal:  J Natl Med Assoc       Date:  1985-03       Impact factor: 1.798

4.  Approach to the jaundiced patient.

Authors:  J A Vennes; J H Bond
Journal:  Gastroenterology       Date:  1983-06       Impact factor: 22.682

5.  Obstruction without dilation. Importance in evaluating jaundice.

Authors:  C Beinart; S Efremidis; B Cohen; H A Mitty
Journal:  JAMA       Date:  1981 Jan 23-30       Impact factor: 56.272

6.  Can acute cholecystitis produce obstructive jaundice in the absence of choledocholithiasis?

Authors:  C Warner; J Densler; W Meadows; J Godwin
Journal:  J Natl Med Assoc       Date:  1986-10       Impact factor: 1.798

7.  Jaundice, choledocholithiasis, and a nondilated common duct.

Authors:  R A Greenwald; R Pereiras; S J Morris; E R Schiff
Journal:  JAMA       Date:  1978-10-27       Impact factor: 56.272

8.  The usefulness of stool screening for diagnosing cholelithiasis in acute pancreatitis. A description of the technique.

Authors:  M J Acosta; R Rossi; C L Ledesma
Journal:  Am J Dig Dis       Date:  1977-02

9.  Non-operative removal of bile duct stones by duodenoscopic sphincterotomy.

Authors:  P B Cotton
Journal:  Br J Surg       Date:  1980-01       Impact factor: 6.939

10.  Endoscopic treatment of biliary-tract diseases. An international study.

Authors:  L Safrany
Journal:  Lancet       Date:  1978-11-04       Impact factor: 79.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.